T. Rowe Price Associates’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-163,592
| Closed | -$265K | – | 2938 |
|
|
2022
Q4 | $265K | Sell |
163,592
-7,594
| -4% | -$12.3K | ﹤0.01% | 2416 |
|
|
2022
Q3 | $575K | Sell |
171,186
-228,125
| -57% | -$766K | ﹤0.01% | 2051 |
|
|
2022
Q2 | $1.45M | Sell |
399,311
-554
| -0.1% | -$2.02K | ﹤0.01% | 1728 |
|
|
2022
Q1 | $2.89M | Sell |
399,865
-1,133,697
| -74% | -$8.2M | ﹤0.01% | 1572 |
|
|
2021
Q4 | $20.8M | Sell |
1,533,562
-239,621
| -14% | -$3.26M | ﹤0.01% | 1277 |
|
|
2021
Q3 | $37.2M | Buy |
1,773,183
+5,512
| +0.3% | +$116K | ﹤0.01% | 1118 |
|
|
2021
Q2 | $42.3M | Sell |
1,767,671
-339,837
| -16% | -$8.14M | ﹤0.01% | 1087 |
|
|
2021
Q1 | $60.3M | Sell |
2,107,508
-6,070
| -0.3% | -$174K | 0.01% | 935 |
|
|
2020
Q4 | $61.7M | Buy |
+2,113,578
| New | +$61.7M | 0.01% | 878 |
|